United States · FDA National Drug Code directory
SYMBRAVO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81968-020_b625951b-f029-470d-8d35-f5b6a92a06bb
- Product NDC
- 81968-020
- Form
- TABLET
- Composition / generic term
- meloxicam, rizatriptan
- Labeler
- Axsome Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250519
- Source listing expiry
- 20261231
Source-listed ingredients
- MELOXICAM — 20 mg/1
- RIZATRIPTAN BENZOATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (81968-020-02) / 2 TABLET in 1 BOTTLE · 81968-020-02
- 1 BOTTLE in 1 CARTON (81968-020-03) / 3 TABLET in 1 BOTTLE · 81968-020-03
- 9 TABLET in 1 BOTTLE (81968-020-09) · 81968-020-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →